SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?


To: TobagoJack who wrote (174685)7/12/2021 6:25:50 PM
From: sense  Read Replies (1) | Respond to of 218534
 
Nailed it... I'd say...

It may be a lie that the vaccine works against variants... but it is not a lie that the one who lies the most, the longest, the best, and most convincingly... will sell the most doses...

That there are different vaccines... that work different ways... also means there may be variable outcomes depending on changes in the future that we don't know about yet...

So, it may well be possible that one works better than the others... in one instance... but kills you in another... where the others don't...

But, don't expect to see that in the marketing any time soon ?

"Vaccine X... 5% less likely to kill you if things go wrong" ?



To: TobagoJack who wrote (174685)7/12/2021 8:24:23 PM
From: marcher1 Recommendation

Recommended By
sense

  Read Replies (2) | Respond to of 218534
 
jnj talking book,
of course,
with plausible deniability.

and, since posting that, i see jnj vax causes guillain-barre syndrome,
per fda:
pharmacytimes.com

which may,of course,
be talking book for pfizer and moderna.
:0)